ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants-Reference-Cited by-同舟云学术

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants

Published:2022-05 Issue:5 Volume:39 Page:110757
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Seow Jeffrey^ORCID,Graham Carl,Hallett Sadie R.^ORCID,Lechmere Thomas,Maguire Thomas J.A.^ORCID,Huettner Isabella,Cox Daniel^ORCID,Khan Hataf,Pickering Suzanne,Roberts Rebekah,Waters Anele,Ward Christopher C.^ORCID,Mant Christine^ORCID,Pitcher Michael J.^ORCID,Spencer Jo,Fox Julie,Malim Michael H.^ORCID,Doores Katie J.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference92 articles.

1. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans;Alter;Nature,2021

2. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2;Amanat;Cell,2021

3. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection;Anderson;Cell,2021

4. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients;Andreano;Cell,2021

5. Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants;Andreano;Nature,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses;Cell Reports;2024-09

2. Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting;2024-08-15

3. SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines;Science Immunology;2024-08-09

4. COVID-19 Vaccines: Where Did We Stand at the End of 2023?;Viruses;2024-01-29

5. The complement pattern recognition molecule CL-11 promotes invasion and injury of respiratory epithelial cells by SARS-CoV-2;2023-12-12